{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:51:30Z","timestamp":1787698290215,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81401064"],"award-info":[{"award-number":["No. 81401064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81771360"],"award-info":[{"award-number":["No. 81771360"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jining science and technology development project","award":["Jikezi [2016]56-6"],"award-info":[{"award-number":["Jikezi [2016]56-6"]}]},{"name":"Shandong medical and health technology development project","award":["2011HZ016"],"award-info":[{"award-number":["2011HZ016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11011-018-0279-2","type":"journal-article","created":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:04:04Z","timestamp":1530403444000},"page":"1711-1720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation"],"prefix":"10.1007","volume":"33","author":[{"given":"Zhanyun","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangchen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,1]]},"reference":[{"key":"279_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2217\/nmt.14.52","volume":"5","author":"LM Bekris","year":"2015","unstructured":"Bekris LM, Leverenz JB (2015) The biomarker and therapeutic potential of miRNA in Alzheimer's disease. Neurodegener Dis Manag 5:61\u201374","journal-title":"Neurodegener Dis Manag"},{"key":"279_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/(SICI)1098-1004(1998)11:6<481::AID-HUMU13>3.0.CO;2-N","volume":"11","author":"R Besancon","year":"1998","unstructured":"Besancon R, Lorenzi A, Cruts M, Radawiec S, Sturtz F, Broussolle E et al (1998) Missense mutation in exon 11 (codon 378) of the presenilin-1 gene in a French family with early-onset Alzheimer's disease and transmission study by mismatch enhanced allele specific amplification. Mutations in brief no. 141. Online. besancon@rockefeller1.univ.lyon1.fr. Hum Mutat 11:481","journal-title":"Hum Mutat"},{"key":"279_CR3","doi-asserted-by":"publisher","first-page":"e94839","DOI":"10.1371\/journal.pone.0094839","volume":"9","author":"K Burgos","year":"2014","unstructured":"Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, Shill H, Adler C, Sabbagh M, Villa S, Tembe W, Craig D, van Keuren-Jensen K (2014) Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS One 9:e94839","journal-title":"PLoS One"},{"key":"279_CR4","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1172\/JCI45390","volume":"121","author":"PS Chen","year":"2011","unstructured":"Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC, Lin MT, Chu CY, Hua KT, Chen CN, Kuo TC, Chang KJ, Hsiao M, Chang YW, Chen JS, Yang PC, Kuo ML (2011) miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 121:3442\u20133455","journal-title":"J Clin Invest"},{"key":"279_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2014.01.016","volume":"563","author":"MR Cornejo-Olivas","year":"2014","unstructured":"Cornejo-Olivas MR, Yu CE, Mazzetti P, Mata IF, Meza M, Lindo-Samanamud S, Leverenz JB, Bird TD (2014) Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's disease. Neurosci Lett 563:140\u2013143","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"279_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-013-1567-0","volume":"376","author":"N Croce","year":"2013","unstructured":"Croce N, Gelfo F, Ciotti MT, Federici G, Caltagirone C, Bernardini S, Angelucci F (2013 Apr) NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection? Mol Cell Biochem 376(1\u20132):189\u2013195","journal-title":"Mol Cell Biochem"},{"key":"279_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.2174\/1567205013666160314150501","volume":"13","author":"J Dorszewska","year":"2016","unstructured":"Dorszewska J, Prendecki M, Oczkowska A, Dezor M, Kozubski W (2016) Molecular basis of familial and sporadic Alzheimer's disease. Curr Alzheimer Res 13:952\u2013963","journal-title":"Curr Alzheimer Res"},{"key":"279_CR8","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K et al (2014) Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 13:614\u2013629","journal-title":"Lancet Neurol"},{"issue":"4","key":"279_CR9","doi-asserted-by":"publisher","first-page":"e89656","DOI":"10.1172\/jci.insight.89656","volume":"2","author":"S Erener","year":"2017","unstructured":"Erener S, Marwaha A, Tan R, Panagiotopoulos C, Kieffer TJ (2017 Feb 23) Profiling of circulating microRNAs in children with recent onset of type 1 diabetes. JCI Insight 2(4):e89656","journal-title":"JCI Insight"},{"issue":"4","key":"279_CR10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3233\/JAD-160149","volume":"52","author":"AM Fernandez","year":"2016","unstructured":"Fernandez AM, Hervas R, Dominguez-Fraile M, Garrido VN, Gomez-Gutierrez P, Vega M, Vitorica J, Perez JJ, Torres Aleman I (2016 Apr 12) Blockade of the interaction of Calcineurin with FOXO in astrocytes protects against amyloid-\u03b2-induced neuronal death. J Alzheimers Dis 52(4):1471\u20131478","journal-title":"J Alzheimers Dis"},{"key":"279_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10048-005-0211-x","volume":"6","author":"U Finckh","year":"2005","unstructured":"Finckh U, Kuschel C, Anagnostouli M, Patsouris E, Pantes GV, Gatzonis S, Kapaki E, Davaki P, Lamszus K, Stavrou D, Gal A (2005) Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics 6:85\u201389","journal-title":"Neurogenetics"},{"key":"279_CR12","doi-asserted-by":"publisher","first-page":"37043","DOI":"10.18632\/oncotarget.6158","volume":"6","author":"Y Gui","year":"2015","unstructured":"Gui Y, Liu H, Zhang L, Lv W, Hu X (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6:37043\u201337053","journal-title":"Oncotarget"},{"key":"279_CR13","doi-asserted-by":"crossref","unstructured":"Guo Y, Sun W, Gong T, Chai Y, Wang J, Hui B et al (2017 Feb 14) miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM. Oncol Rep","DOI":"10.3892\/or.2017.5448"},{"issue":"3","key":"279_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1159\/000460618","volume":"41","author":"X Han","year":"2017","unstructured":"Han X, Zhen S, Ye Z, Lu J, Wang L, Li P, Li J, Zheng X, Li H, Chen W, Zhao L, Li X (2017 Feb 21) A feedback loop between miR-30a\/c-5p and DNMT1 mediates cisplatin resistance in ovarian Cancer cells. Cell Physiol Biochem 41(3):973\u2013986","journal-title":"Cell Physiol Biochem"},{"key":"279_CR15","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"SS Hebert","year":"2008","unstructured":"Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, de Strooper B (2008) Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer's disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci U S A 105:6415\u20136420","journal-title":"Proc Natl Acad Sci U S A"},{"key":"279_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000141483","volume":"26","author":"T Ikeuchi","year":"2008","unstructured":"Ikeuchi T, Kaneko H, Miyashita A, Nozaki H, Kasuga K, Tsukie T, Tsuchiya M, Imamura T, Ishizu H, Aoki K, Ishikawa A, Onodera O, Kuwano R, Nishizawa M (2008) Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations. Dement Geriatr Cogn Disord 26:43\u201349","journal-title":"Dement Geriatr Cogn Disord"},{"key":"279_CR17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/jnc.12400","volume":"127","author":"S Jayadev","year":"2013","unstructured":"Jayadev S, Case A, Alajajian B, Eastman AJ, Moller T, Garden GA (2013) Presenilin 2 influences miR146 level and activity in microglia. J Neurochem 127:592\u2013599","journal-title":"J Neurochem"},{"key":"279_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-130932","volume":"39","author":"T Kiko","year":"2014","unstructured":"Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T (2014) MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. J Alzheimers Dis 39:253\u2013259","journal-title":"J Alzheimers Dis"},{"key":"279_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nn.3113","volume":"15","author":"SM Lehmann","year":"2012","unstructured":"Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J et al (2012) An unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15:827\u2013835","journal-title":"Nat Neurosci"},{"key":"279_CR20","first-page":"1565","volume":"8","author":"X Lei","year":"2015","unstructured":"Lei X, Lei L, Zhang Z, Zhang Z, Cheng Y (2015) Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease. Int J Clin Exp Pathol 8:1565\u20131574","journal-title":"Int J Clin Exp Pathol"},{"key":"279_CR21","doi-asserted-by":"publisher","first-page":"36136","DOI":"10.1038\/srep36136","volume":"6","author":"Y Li","year":"2016","unstructured":"Li Y, Zhang T, Zhou Y, Sun Y, Cao Y, Chang X, Zhu Y, Han X (2016 Nov 2) A Presenilin\/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis. Sci Rep 6:36136","journal-title":"Sci Rep"},{"key":"279_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fgene.2012.00166","volume":"3","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ, Andreeva TV, Grigorenko AP, Rogaev EI (2012) Studying micro RNA function and dysfunction in Alzheimer's disease. Front Genet 3:327","journal-title":"Front Genet"},{"issue":"8","key":"279_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101725","volume":"9","author":"H Luo","year":"2014","unstructured":"Luo H, Wu Q, Ye X, Xiong Y, Zhu J, Xu J, Diao Y, Zhang D, Wang M, Qiu J, Miao J, Zhang W, Wan J (2014 Aug 22) Genome-wide analysis of miRNA signature in the APPswe\/PS1\u0394E9 mouse model of alzheimer'sdisease. PLoS One 9(8):e101725","journal-title":"PLoS One"},{"key":"279_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2016.10.014","volume":"301","author":"Z Lv","year":"2016","unstructured":"Lv Z, Shi Q, Huang W, Xing C, Hao Y, Feng X et al (2016) MicroRNA expression profiling in Guillain-Barr\u00e9 syndrome. J Neuroimmunol 301:12\u201315","journal-title":"J Neuroimmunol"},{"key":"279_CR25","first-page":"569392","volume":"2015","author":"K Maiese","year":"2015","unstructured":"Maiese K (2015) FoxO proteins in the nervous system. Anal Cell Pathol (Amst) 2015:569392","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"11","key":"279_CR26","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/mp.2010.17","volume":"15","author":"KN Manolopoulos","year":"2010","unstructured":"Manolopoulos KN, Klotz LO, Korsten P, Bornstein SR, Barthel A (2010 Nov) Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress. Mol Psychiatry 15(11):1046\u20131052","journal-title":"Mol Psychiatry"},{"issue":"19","key":"279_CR27","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1093\/hmg\/ddn201","volume":"17","author":"N Mellios","year":"2008","unstructured":"Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S (2008 Oct 1) A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitorsof BDNF in prefrontal cortex. Hum Mol Genet 17(19):3030\u20133042","journal-title":"Hum Mol Genet"},{"key":"279_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fgene.2016.00197","volume":"7","author":"F Meng","year":"2016","unstructured":"Meng F, Wang F, Wang L, Wong SC, Cho WC, Chan LW (2016 Nov 15) MiR-30a-5p overexpression may overcome EGFR-inhibitor resistance through regulating PI3K\/AKT signaling pathway in non-small cell lung Cancer cell lines. Front Genet 7:197","journal-title":"Front Genet"},{"key":"279_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neurobiolaging.2013.07.005","volume":"35","author":"M Muller","year":"2014","unstructured":"Muller M, Kuiperij HB, Claassen JA, Kusters B, Verbeek MM (2014) MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging 35:152\u2013158","journal-title":"Neurobiol Aging"},{"key":"279_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-150451","volume":"49","author":"Y Pan","year":"2015","unstructured":"Pan Y, Liu R, Terpstra E, Wang Y, Qiao F, Wang J, Tong Y, Pan B (2015) Dysregulation and diagnostic potential of microRNA in Alzheimer's disease. J Alzheimers Dis 49:1\u201312","journal-title":"J Alzheimers Dis"},{"key":"279_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuron.2014.02.011","volume":"82","author":"CK Park","year":"2014","unstructured":"Park CK, Xu ZZ, Berta T, Han Q, Chen G, Liu XJ, Ji RR (2014) Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 82:47\u201354","journal-title":"Neuron"},{"key":"279_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/bs.pmbts.2016.12.016","volume":"146","author":"S Pugazhenthi","year":"2017","unstructured":"Pugazhenthi S (2017) Metabolic syndrome and the cellular phase of Alzheimer's disease. Prog Mol Biol Transl Sci 146:243\u2013258","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"3","key":"279_CR33","first-page":"208","volume":"50","author":"W Quanquan","year":"2017","unstructured":"Quanquan W, Yanlei H, Yan Y, Qingxia K, Shuhu Z, Zhanyun L (2017 march) A Chinese pedigree with early-onset familial Alzheimer\u2019s disease caused by presenilin 1 p.G378E. Chin J Neurol 50(3):208\u2013212","journal-title":"Chin J Neurol"},{"key":"279_CR34","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1007\/s12035-015-9484-8","volume":"53","author":"RJ Ren","year":"2016","unstructured":"Ren RJ, Zhang YF, Dammer EB, Zhou Y, Wang LL, Liu XH, Feng BL, Jiang GX, Chen SD, Wang G, Cheng Q (2016) Peripheral blood MicroRNA expression profiles in Alzheimer's disease: screening, validation, association with clinical phenotype and implications for molecular mechanism. Mol Neurobiol 53:5772\u20135781","journal-title":"Mol Neurobiol"},{"issue":"7","key":"279_CR35","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.2337\/db15-1428","volume":"65","author":"Mini Sajan","year":"2016","unstructured":"Sajan M, Hansen B, Ivey R. 3rd, Sajan J, Ari C, Song S, et al. Brain insulin signaling is increased in insulin-resistant states and decreases in FOXOs and PGC-1\u03b1 and increases in A\u03b21-40\/42 and Phospho-tau may abet Alzheimer development. Diabetes 2016 Jul;65(7):1892\u20131903","journal-title":"Diabetes"},{"key":"279_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4137\/BMI.S25132","volume":"10","author":"J Satoh","year":"2015","unstructured":"Satoh J, Kino Y, Niida S (2015) MicroRNA-Seq data analysis pipeline to identify blood biomarkers for Alzheimer's disease from public data. Biomark Insights 10:21\u201331","journal-title":"Biomark Insights"},{"issue":"1","key":"279_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12883-016-0765-2","volume":"16","author":"O Shafi","year":"2016","unstructured":"Shafi O (2016 Nov 22) Inverse relationship between Alzheimer's disease and cancer, and other factors contributing toAlzheimer's disease: a systematic review. BMC Neurol 16(1):236","journal-title":"BMC Neurol"},{"key":"279_CR38","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s12035-015-9145-y","volume":"53","author":"KL Shamsuzzama","year":"2016","unstructured":"Shamsuzzama KL, Haque R, Nazir A (2016) Role of MicroRNA Let-7 in modulating multifactorial aspect of neurodegenerative diseases: an overview. Mol Neurobiol 53:2787\u20132793","journal-title":"Mol Neurobiol"},{"key":"279_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fnagi.2015.00061","volume":"7","author":"J Song","year":"2015","unstructured":"Song J, Lee JE (2015) miR-155 is involved in Alzheimer's disease by regulating T lymphocyte function. Front Aging Neurosci 7:61","journal-title":"Front Aging Neurosci"},{"key":"279_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-016-0053-5","volume":"5","author":"SS Sorensen","year":"2016","unstructured":"Sorensen SS, Nygaard AB, Christensen T (2016) miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study. Transl Neurodegener 5:6","journal-title":"Transl Neurodegener"},{"key":"279_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-9-2","volume":"9","author":"LM Tai","year":"2014","unstructured":"Tai LM, Mehra S, Shete V, Estus S, Rebeck GW, Bu G, LaDu M (2014) Soluble apoE\/Abeta complex: mechanism and therapeutic target for APOE4-induced AD risk. Mol Neurodegener 9:2","journal-title":"Mol Neurodegener"},{"key":"279_CR42","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3233\/JAD-132144","volume":"40","author":"L Tan","year":"2014","unstructured":"Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T, Tan L (2014) Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J Alzheimers Dis 40:1017\u20131027","journal-title":"J Alzheimers Dis"},{"key":"279_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jns.2015.12.005","volume":"360","author":"V Giau Van","year":"2016","unstructured":"Van Giau V, An SS (2016) Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease. J Neurol Sci 360:141\u2013152","journal-title":"J Neurol Sci"},{"issue":"3","key":"279_CR44","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1159\/000447823","volume":"39","author":"W Wei","year":"2016","unstructured":"Wei W, Yang Y, Cai J, Cui K, Li RX, Wang H et al (2016) MiR-30a-5p suppresses tumor metastasis of human colorectal Cancer by targeting ITGB3. Cell Physiol Biochem 39(3):1165\u20131176","journal-title":"Cell Physiol Biochem"},{"key":"279_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12035-013-8595-3","volume":"50","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ (2014) Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol 50:97\u2013106","journal-title":"Mol Neurobiol"},{"key":"279_CR46","doi-asserted-by":"publisher","first-page":"30105","DOI":"10.3390\/ijms161226223","volume":"16","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Pogue AI, Lukiw WJ (2015) MicroRNA (miRNA) signaling in the human CNS in sporadic Alzheimer's disease (AD)-novel and unique pathological features. Int J Mol Sci 16:30105\u201330116","journal-title":"Int J Mol Sci"},{"issue":"1","key":"279_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-017-0591-1","volume":"16","author":"J Zhu","year":"2017","unstructured":"Zhu J, Zeng Y, Li W, Qin H, Lei Z, Shen D, Gu D, Huang JA, Liu Z (2017 Feb 3) CD73\/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Mol Cancer 16(1):34","journal-title":"Mol Cancer"},{"key":"279_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2011.04.035","volume":"1395","author":"Y Zong","year":"2011","unstructured":"Zong Y, Wang H, Dong W, Quan X, Zhu H, Xu Y, Huang L, Ma C, Qin C (2011) miR-29c regulates BACE1 protein expression. Brain Res 1395:108\u2013115","journal-title":"Brain Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-018-0279-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0279-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0279-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T21:07:53Z","timestamp":1561928873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-018-0279-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["279"],"URL":"https:\/\/doi.org\/10.1007\/s11011-018-0279-2","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,1]]},"assertion":[{"value":"23 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent for publication was obtained from patients. A copy of the written consent is available for review to the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study protocol was approved by the Ethics Committees of the Affiliated Hospital of Jining Medical University, and all participants provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}